Deadly Disease DOUBLES

Red alert light against black background, text ALERT.
DEADLY DISEASE DOUBLES

Chronic kidney disease has silently surged to become the ninth leading cause of death worldwide, with cases more than doubling in three decades, while Americans face skyrocketing healthcare costs and government health agencies fail to address this deadly epidemic.

Story Highlights

  • Chronic kidney disease cases doubled from 378 million to 788 million between 1990-2023, now ranking as the ninth leading cause of global death.
  • About 14% of the world’s adult population suffers from chronic kidney disease, with 1.5 million deaths in 2023 alone.
  • The disease remains vastly underdiagnosed and undertreated despite being preventable in early stages through lifestyle changes.
  • High blood sugar, blood pressure, and obesity drive most cases, reflecting America’s broader health crisis from poor dietary habits.

Silent Epidemic Reaches Crisis Levels

A comprehensive study published in The Lancet reveals that chronic kidney disease has exploded into a global health crisis that government health officials have largely ignored.

Researchers from NYU Langone Health, the University of Glasgow, and the Institute for Health Metrics and Evaluation analyzed 2,230 published papers and health datasets from 133 countries. The findings expose a devastating trend: kidney disease cases surged from 378 million in 1990 to 788 million in 2023, marking the first time this condition cracked the top 10 deadliest diseases worldwide.

Government Health Agencies Miss the Mark

While federal health bureaucrats focus on politically driven initiatives, this life-threatening condition affects approximately 14% of the world’s adult population, with minimal public awareness campaigns.

The research shows 1.5 million people died from kidney disease in 2023, representing a 6% increase since 1993. Most concerning, the majority of patients remain in early stages where the disease can be reversed through drugs and lifestyle changes before expensive dialysis or surgery becomes necessary. This represents a massive failure of preventive healthcare that could save both lives and taxpayer dollars.

Lifestyle Factors Drive Healthcare Crisis

The study identified the primary culprits behind this epidemic: high blood sugar, high blood pressure, and elevated body mass index. These factors reflect America’s broader health crisis driven by processed foods, sedentary lifestyles, and poor dietary habits that have become normalized in modern society.

Fox News senior medical analyst Dr. Marc Siegel noted the “dramatic increase” stems from kidney disease being “vastly underestimated and underdiagnosed” due to a lack of early symptoms. The kidneys filter waste products and regulate electrolyte balance, making them highly sensitive to changes in blood pressure and lifestyle factors.

Medical Establishment Fails Patients

Study co-lead author Dr. Morgan Grams acknowledged chronic kidney disease remains “underdiagnosed and undertreated” despite being highly preventable.

The medical establishment’s failure to implement proper screening protocols has allowed this condition to reach epidemic proportions. Impaired kidney function also contributes to approximately 12% of global cardiovascular deaths, creating a cascade of health complications.

New medications can slow disease progression and reduce heart attack risk, but many patients cannot access or afford these treatments under current healthcare policies.

Economic Impact on American Families

This health crisis represents a significant economic burden on American families already struggling with inflation and rising healthcare costs. Advanced kidney disease requires dialysis, kidney replacement therapy, or organ transplants that can financially devastate middle-class families.

The research underscores the need for more accessible urine testing and affordable treatment options. Dr. Josef Coresh classified chronic kidney disease as “common, deadly and getting worse” while calling for policymakers to prioritize this condition alongside cancer and heart disease, though meaningful action remains unlikely under current government priorities.